Pre-Conditions for the Growth of Addiction
The United States faces a severe drug crisis, with over 100,000 overdose deaths reported nationally in 2022, driven primarily by opioids including illicit fentanyl. In North Carolina specifically, more than 36,000 people have died from overdoses between 2000 and 2022, with opioids involved in 78.9% of cases. Marijuana addiction contributes less to mortality but is part of broader substance use trends, though opioids remain the dominant factor in fatal overdoses.
The crisis originated from overprescription of opioid painkillers in the late 1990s, leading to widespread dependency as pharmaceutical companies downplayed addiction risks. As prescriptions tightened, users shifted to heroin and then illicit fentanyl, which is far more potent and often mixed unknowingly into other drugs, accelerating overdose rates. Economic despair in rural and deindustrialized areas fueled initial uptake, compounded by inadequate treatment access and the fentanyl supply chain from Mexico. The COVID-19 pandemic worsened the situation through isolation, disrupted services, and increased drug potency, though recent national declines of about 13% in overdose deaths from 2023 to 2024 signal some progress.
Social and Economic Impacts
Opioid addiction has overwhelmed U.S. healthcare systems, with North Carolina alone seeing over 11 daily overdose deaths in provisional 2022 data, leading to strained emergency departments and 10,627 overdose-related ED visits at a rate of 96.2 per 100,000 residents in 2025. Public safety is compromised as overdoses surpass other accidental deaths, with those recently incarcerated facing a 50 times higher overdose risk post-release, contributing to cycles of crime and emergency responses. Productivity suffers immensely, as addiction leads to workforce absenteeism, with national estimates linking the crisis to billions in lost economic output; in North Carolina, uneven recovery post-Hurricane Helene risks further setbacks in affected communities. Marijuana, while less lethal, exacerbates mental health burdens and youth initiation, indirectly straining healthcare resources amid co-use with opioids.
Broader economic impacts include massive settlement funds—North Carolina expects $1.4 billion through 2038 from opioid lawsuits, with $98 million already received—to address remediation, yet disparities persist in marginalized communities where overdose declines are uneven. Public safety challenges extend to disrupted drug supplies post-disasters like Hurricane Helene, potentially spiking overdoses due to unknown potencies and housing loss. Overall productivity losses from addiction hinder state growth, as families face child welfare crises and communities bear long-term recovery costs, underscoring the need for sustained interventions beyond immediate healthcare responses.
Federal Countermeasures
SUPPORT for Patients and Communities Act (2023 Reauthorization) This act expands access to medications for opioid use disorder (MOUD) like buprenorphine and methadone through telehealth and removes prescribing barriers post-COVID flexibilities. It targets healthcare providers and patients in underserved areas, funding state grants for treatment infrastructure. By increasing MOUD availability, it reduces withdrawal risks and relapse, contributing to national overdose declines observed by CDC at 13% from 2023-2024. Evidence shows states with higher MOUD penetration see 20-50% lower overdose rates.
CDC Overdose Data to Action (ODA) Initiative (Ongoing, Updated 2024) ODA provides funding and tools for state surveillance of overdose trends, enabling rapid response to hotspots. It targets public health departments, integrating provisional data like NVSS reports for real-time tracking of fentanyl and polysubstance deaths. This contributes by informing targeted naloxone distribution and interventions, directly aiding declines like North Carolina’s 30% drop from May 2023-2024.
HHS Overdose Prevention Strategy (2025 Update) This strategy coordinates federal agencies to prioritize harm reduction, including naloxone and fentanyl test strips nationwide. It targets high-risk populations like those post-incarceration, with grants for community-based programs. By scaling evidence-based tools, it has supported provisional national death reductions and addresses marijuana co-use through integrated behavioral health.
National Opioid Settlement Agreements (Distributing since 2022) These $26 billion+ settlements from pharmaceutical companies fund state and local abatement, mandating uses for treatment and recovery. They target communities via dashboards like NCDHHS’s, ensuring transparency and effective spending. In practice, they enable programs like post-overdose response teams, reducing repeat overdoses by connecting users to care.
DEA Fentanyl Precursor Crackdown (2024-2025 Enforcement Surge) The DEA targets international suppliers of fentanyl precursors, seizing record amounts and disrupting supply chains. It focuses on cartels and ports, collaborating with Mexico. This supply reduction complements demand-side efforts, correlating with CDC-noted declines in synthetic opioid deaths.
North Carolina Case – The Numbers Speak for Themselves
North Carolina’s overdose crisis shows promising declines, with provisional CDC data indicating a 30% drop in deaths from May 2023 to May 2024, compared to the national 13%, though final figures await death certificate processing amid medical examiner backlogs. Opioids drive 78.9% of overdoses, with over 4,400 estimated deaths in 2023 at a rate of 38.5 per 100,000; marijuana is rarely a direct cause of mortality but factors in polysubstance cases. Detailed statistics on these trends are available at https://www.wfmh.org/stats/north-carolina-drug-alcohol-statistics, offering insight into the scope of the crisis. Local authorities respond via the NC Opioid and Substance Use Action Plan, leveraging $1.4 billion in expected settlement funds for prevention and treatment.
NC Opioid and Substance Use Action Plan This comprehensive dashboard-guided strategy outlines prevention, harm reduction, and care linkage using settlement funds. It works through data-driven allocations to counties for MOUD and naloxone, targeting high-risk areas. Its impact includes supporting the observed 27% drop in suspected September 2024 overdoses versus 2023.
Naloxone Distribution Program Funded by settlements, it provides free naloxone kits to reverse overdoses, distributed via pharmacies and community sites. It operates statewide, prioritizing post-incarceration and disaster-affected zones. Scope reaches thousands, aiding overall death declines per CDC provisional data.
Post-Overdose Response Teams These teams link non-fatal overdose survivors to treatment and recovery supports immediately post-event. Supported by Richmond County DEFT and statewide MOA, they deploy via EMS coordination. Impact reduces recidivism, aligning with 50x post-jail risk data.
Approaches in Neighboring Regions
- Virginia
- Virginia’s Comprehensive Opioid Overdose Response Plan integrates MOUD in all state prisons, reducing post-release deaths by 40% through continuous treatment.
- It funds mobile clinics for rural access, addressing geographic barriers similar to NC’s west.
- Settlement funds support data dashboards mirroring NC’s for real-time interventions.
- Harm reduction emphasizes fentanyl testing, contributing to regional declines.
- South Carolina
- SC’s Behavioral Health Services Transformation uses $100M+ settlements for 24/7 crisis centers, diverting overdoses from EDs.
- Post-overdose protocols mandate follow-up care, lowering repeat incidents.
- Youth prevention via school-based naloxone training shows sustained engagement.
- Interagency cooperation with law enforcement aids non-arrest responses.
- Tennessee
- TN’s TN Together allocates settlements to recovery housing networks, housing 5,000+ annually.
- Focus on polysubstance including marijuana via integrated treatment models.
- Xylazine detection kits combat emerging threats alongside fentanyl.
- Workforce reentry programs tackle productivity losses post-treatment.
Is It Possible to Stop the Crisis? Looking to the Future
Potentially Effective Approaches:
- Investment in Treatment (MOUD Expansion): Scaling medications like buprenorphine prevents withdrawal and relapse, with states showing 30-50% overdose reductions; NC’s jail access improvements exemplify this.
- Early Intervention: School and community programs identify at-risk youth, curbing initiation; data links them to 20% lower adult addiction rates.
- Interagency Cooperation: Aligning health, justice, and EMS as in post-overdose teams accelerates care linkage, reducing 50x post-incarceration risks.
- Educational Campaigns: Fentanyl awareness and naloxone training save lives, supporting NC’s 30% decline.
- Harm Reduction (Naloxone/Test Strips): Immediate reversal tools lower mortality without increasing use, per CDC trends.
Likely Ineffective Approaches:
- Unaccompanied Isolation: Cold turkey detox without meds leads to 80% relapse; lacks support structure.
- Repressive Measures Alone: Enforcement without treatment ignores demand, as seen in shifting supplies post-crackdowns.
- Lack of Aftercare: Discharge without follow-up spikes deaths, especially post-jail (50x risk).
Conclusions and Recommendations
Public health is a collective responsibility demanding urgency and evidence-based action. Each state charts its path—North Carolina’s declining overdoses via settlements and plans offer a model—but success hinges on reliable data like CDC provisional reports, open stakeholder dialogue, and sustained long-term support for those in recovery.